| Financial Year |
March 31 2023 |
| Monetary Funds |
303,331,124.92 |
| Held-for-trading Financial Assets |
2,303,980.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
160,612,240.79 |
| Advances to Suppliers |
62,472,100.21 |
| Other Receivables |
60,959,355.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
475,044,191.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
72,915,221.25 |
| Total Current Assets |
1,358,920,825.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,992,230.36 |
| Investment Properties |
9,457,066.97 |
| Fixed Assetes |
3,712,063,310.04 |
| Under-construction Projects |
68,995,834.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
688,440,765.72 |
| R&D expenses |
-- |
| Goodwill |
27,437,443.26 |
| Long-Term Deferred and Prepaid Expenses |
1,205,777,322.86 |
| Deferred Income Tax Assets |
90,653,115.46 |
| Other Non-Current Assets |
13,857,913.30 |
| Sub-Total of Non-Current Assets |
5,834,175,002.41 |
| Total Assets |
7,193,095,827.92 |
| Short-Term Loans |
60,000,000.00 |
| Trading Financial liabilities |
43,207,988.31 |
| Notes Payable |
-- |
| Accounts Payable |
372,535,756.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
264,456,419.15 |
| Taxes Payable |
47,853,922.71 |
| Interest Payable |
-- |
| Dividend Payable |
244,680.31 |
| Other payables |
114,117,409.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
5,298,229.46 |
| Sub-Total of Current Liabilities |
985,307,417.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
27,317,552.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
129,821,362.02 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
1,212,154.28 |
| Sub-Total of Non-Current Liabilities |
192,597,634.52 |
| Total Liabilities |
1,177,905,052.32 |
| Paid-In Capital(Or Share Stock) |
1,202,039,474.00 |
| Capital Surplus |
1,289,317,677.17 |
| Surplus Reserve |
279,792,318.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,154,489,701.80 |
| Minority Stockholder's Interest |
70,950,358.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,944,240,417.39 |
| Owner's Equity（Stockholder's Equity） |
6,015,190,775.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,193,095,827.92 |
